Stockscreener 앱 받기
287.58
0.43%
-1.05
전일 마감가:
$288.63
열려 있는:
$289.26
하루 거래량:
278.61K
Relative Volume:
0.43
시가총액:
$20.22B
수익:
$2.36B
순이익/손실:
$236.10M
주가수익비율:
87.52
EPS:
3.286
순현금흐름:
$382.50M
1주 성능:
-1.43%
1개월 성능:
-12.16%
6개월 성능:
-8.21%
1년 성능:
+8.40%
1일 변동 폭
$285.58
$290.60
1주일 범위
$285.02
$292.75
52주 변동 폭
$230.05
$354.88
인슐렛 코퍼레이션 Stock (PODD) Company Profile
명칭
Insulet Corporation
전화
978-600-7000
주소
100 NAGOG PARK, ACTON, MA
PODD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PODD
Insulet Corporation
|
287.49 | 20.30B | 2.36B | 236.10M | 382.50M | 3.286 |
|
ABT
Abbott Laboratories
|
124.71 | 217.08B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
95.86 | 142.40B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
353.00 | 135.46B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
96.16 | 123.74B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
86.86 | 50.40B | 5.88B | 1.34B | 799.60M | 2.3489 |
인슐렛 코퍼레이션 Stock (PODD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-16 | 개시 | Evercore ISI | Outperform |
| 2025-11-19 | 업그레이드 | UBS | Neutral → Buy |
| 2025-10-21 | 재개 | Stifel | Buy |
| 2025-09-08 | 재개 | Oppenheimer | Outperform |
| 2025-06-16 | 개시 | Truist | Buy |
| 2025-05-30 | 개시 | Goldman | Buy |
| 2025-05-13 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-04-29 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2025-03-06 | 개시 | RBC Capital Mkts | Outperform |
| 2024-11-06 | 개시 | Bernstein | Outperform |
| 2024-05-30 | 개시 | Redburn Atlantic | Buy |
| 2024-05-07 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-12-21 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2023-12-04 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-02 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-08-21 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-08-21 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-01-26 | 개시 | Wolfe Research | Peer Perform |
| 2022-11-04 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-10-18 | 개시 | Barclays | Equal Weight |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-07-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-03 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-02-02 | 업그레이드 | UBS | Neutral → Buy |
| 2022-01-31 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-07-21 | 재개 | Cowen | Outperform |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-01 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2021-03-19 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2021-01-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-07-28 | 개시 | Wells Fargo | Overweight |
| 2020-04-24 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-03 | 개시 | BofA/Merrill | Neutral |
| 2020-03-31 | 다운그레이드 | Berenberg | Buy → Hold |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2019-12-10 | 개시 | CFRA | Sell |
| 2019-10-23 | 개시 | Stifel | Hold |
| 2019-10-18 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2019-10-14 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2019-10-04 | 다운그레이드 | UBS | Buy → Neutral |
| 2019-10-03 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-08-06 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-06-10 | 다운그레이드 | Northland Capital | Outperform → Market Perform |
| 2019-05-06 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2018-04-20 | 개시 | Berenberg | Buy |
| 2018-02-22 | 재확인 | Barclays | Overweight |
| 2018-01-08 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2017-11-03 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2017-09-15 | 개시 | Barclays | Overweight |
모두보기
인슐렛 코퍼레이션 주식(PODD)의 최신 뉴스
From Edwards to Insulet: Three key medical device cases of 2025 - Life Sciences Intellectual Property Review
Swedbank AB Buys 5,000 Shares of Insulet Corporation $PODD - MarketBeat
Osaic Holdings Inc. Purchases 5,309 Shares of Insulet Corporation $PODD - MarketBeat
Beacon Investment Advisory Services Inc. Has $25.11 Million Stake in Insulet Corporation $PODD - MarketBeat
3 Reasons Growth Investors Will Love Insulet (PODD) - sharewise.com
Insulet Corporation $PODD Holdings Decreased by Squarepoint Ops LLC - MarketBeat
Insulet Corporation $PODD Shares Acquired by Munro Partners - MarketBeat
Insulet Corp. Stock Underperforms Tuesday When Compared To Competitors - 富途牛牛
Insulin Delivery Devices Market Outlook: Market to Reach US$ - openPR.com
Patton Fund Management Inc. Buys 13,972 Shares of Insulet Corporation $PODD - MarketBeat
Why Insulet (PODD) is a Top Growth Stock for the Long-Term - sharewise.com
Insulet Corporation's (NASDAQ:PODD) Business Is Yet to Catch Up With Its Share Price - 富途牛牛
Truist Cuts Insulet (PODD) PT but Maintains Buy as Top MedTech Pick for 2026 - Insider Monkey
Is Insulet Fairly Priced After Its Strong Run and High Earnings Multiple in 2025? - simplywall.st
Voya Investment Management LLC Has $19.59 Million Stock Holdings in Insulet Corporation $PODD - MarketBeat
(PODD) Risk Channels and Responsive Allocation - Stock Traders Daily
Tubeless Insulin Pumps Market Size, Share, Trends | Top - openPR.com
Congress Asset Management Co. Acquires 9,976 Shares of Insulet Corporation $PODD - MarketBeat
Why Insulet Corporation (GOV) stock is a strong analyst pick2025 Technical Patterns & AI Powered Market Entry Strategies - Улправда
Perpetual Ltd Sells 5,898 Shares of Insulet Corporation $PODD - MarketBeat
Should Insulet’s (PODD) Expanded Pod Recycling Effort Reframe Its Long‑Term Sustainability Edge? - Yahoo Finance UK
Guidance Update: Can Insulet Corporation (GOV) stock sustain revenue momentum2025 Growth vs Value & Weekly Breakout Watchlists - moha.gov.vn
Insulet appoints PwC as new auditor for 2026, replaces Grant Thornton By Investing.com - Investing.com Nigeria
Insulet appoints PwC as new auditor for 2026, replaces Grant Thornton - Investing.com Nigeria
Insulet Corp. stock underperforms Friday when compared to competitors - MarketWatch
Returns Recap: Will Insulet Corporation stock outperform value stocksIPO Watch & Risk Controlled Daily Trade Plans - Улправда
Why analysts upgrade Insulet Corporation stockTrade Analysis Summary & Free Accurate Trade Setup Notifications - DonanımHaber
FOMO Trade: Why Insulet Corporation stock attracts high net worth investorsJuly 2025 Market Mood & Weekly Chart Analysis and Trade Guides - Улправда
Why institutional investors increase stakes in Insulet Corporation (GOV) stockJuly 2025 Intraday Action & Expert Approved Trade Ideas - DonanımHaber
Texas Permanent School Fund Corp Purchases 3,633 Shares of Insulet Corporation $PODD - MarketBeat
Why Insulet Corporation stock attracts global investorsExit Point & Short-Term Swing Trade Alerts - Улправда
Assenagon Asset Management S.A. Raises Stock Position in Insulet Corporation $PODD - MarketBeat
Is Insulet Corporation (GOV) stock positioned for digital growth era2025 Risk Factors & Low Drawdown Investment Ideas - DonanımHaber
What margin trends mean for Insulet Corporation stockJuly 2025 Technicals & Growth-Oriented Investment Plans - DonanımHaber
Insulet Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Insulet stock price target lowered to $203 by BofA Securities - Investing.com South Africa
Insulet’s New Omnipod M Study Targets the Untapped Type 2 Diabetes Pump Market - TipRanks
Insulet stock price target maintained at $400 by UBS on growth outlook - Investing.com Nigeria
Insulet (PODD) Analyst Rating Update: Truist Securities Lowers P - GuruFocus
Truist Financial Issues Pessimistic Forecast for Insulet (NASDAQ:PODD) Stock Price - MarketBeat
Truist Securities Lowers Price Target on Insulet to $390 From $412, Maintains Buy Rating - marketscreener.com
UBS Reiterates Buy Rating on Insulet Corporation (PODD) - StreetInsider
Evercore ISI Begins Coverage on Insulet (NASDAQ:PODD) - MarketBeat
Why Insulet Corporation stock attracts high net worth investorsIndex Update & Risk Controlled Swing Alerts - Улправда
Insulet Corporation (PODD) PT Lowered to $203 at BofA Securities - StreetInsider
Central Pacific Bank Trust Division Reduces Stock Holdings in Insulet Corporation $PODD - MarketBeat
Is Insulet stock underperforming the Nasdaq? - MSN
Insulet Corporation (PODD) Announces Amendments to Annual Incentive Plan - GuruFocus
A Look Into Insulet Inc's Price Over Earnings - Sahm
Insulet Corporation (PODD) revises Annual Incentive Plan terms for 2026 - Stock Titan
Insulet (PODD): Canaccord Genuity Raises Price Target to $450 | - GuruFocus
인슐렛 코퍼레이션 (PODD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.42%
0.51%
자본화:
|
볼륨(24시간):